Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn

Johannes Reuscha Dynamic Biosensors GmbH, Munich, Germany;b Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, GermanyView further author information

Jan Terje Andersenc Department of Immunology, Oslo University Hospital Rikshospitalet, Oslo, Norway;d Institute of Clinical Medicine, Department of Pharmacology, University of Oslo, Oslo, Norway;e Precision Immunotherapy Alliance (PRIMA), University of Oslo, Oslo, NorwayView further author information

Ulrich Ranta Dynamic Biosensors GmbH, Munich, GermanyCorrespondence[email protected]
View further author information

Tilman Schlothauerb Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, GermanyCorrespondence[email protected]

https://orcid.org/0000-0001-5844-4438 View further author information

Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date